Difference between revisions of "Small cell carcinoma of the lung"
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
| Gross = | | Gross = | ||
| Grossing = | | Grossing = | ||
| Site = | | Site = [[lung]] - see ''[[lung tumours]]'' | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = [[smoking]] - usually a long history, heavy | | Clinicalhx = [[smoking]] - usually a long history, heavy | ||
| Signs = | | Signs = +/-hemoptysis | ||
| Symptoms = | | Symptoms = | ||
| Prevalence = not common | | Prevalence = not common | ||
| Bloodwork = | | Bloodwork = | ||
| Rads = | | Rads = lung mass, usu. central location | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = poor | | Prognosis = poor | ||
Line 45: | Line 45: | ||
Precursor lesion - uncommonly seen: | Precursor lesion - uncommonly seen: | ||
*Pulmonary neuroendocrine cell hyperplasia.<ref name=pmid20943645>{{Cite journal | last1 = Travis | first1 = WD. | title = Advances in neuroendocrine lung tumors. | journal = Ann Oncol | volume = 21 Suppl 7 | issue = | pages = vii65-71 | month = Oct | year = 2010 | doi = 10.1093/annonc/mdq380 | PMID = 20943645 }}</ref> | *Pulmonary neuroendocrine cell hyperplasia.<ref name=pmid20943645>{{Cite journal | last1 = Travis | first1 = WD. | title = Advances in neuroendocrine lung tumors. | journal = Ann Oncol | volume = 21 Suppl 7 | issue = | pages = vii65-71 | month = Oct | year = 2010 | doi = 10.1093/annonc/mdq380 | PMID = 20943645 }}</ref> | ||
Clinical: | |||
*+/-Hemoptysis. | |||
==Gross== | ==Gross== |
Revision as of 14:15, 5 January 2014
Small cell carcinoma of the lung | |
---|---|
Diagnosis in short | |
Lung small cell carcinoma. H&E stain. | |
| |
LM | stippled chromatin, high NC ratio with scant basophilic cytoplasm, typically small cells (~2x RBC diameter), +/-nuclear moulding, nuclei with smudgy appearance (Azzopardi phenomenon), necrosis, mitoses |
Subtypes | large cell neuroendocrine carcinoma (LCNEC) |
LM DDx | poorly differentiated adenocarcinoma of the lung, atypical carcinoid, lung carcinoid, metastatic small cell carcinoma, lymphoma, other small round blue cell tumours |
Stains | chromogranin +ve, synaptophysin +ve, CD56 +ve, NSE +ve, TTF-1 +ve |
Site | lung - see lung tumours |
| |
Clinical history | smoking - usually a long history, heavy |
Signs | +/-hemoptysis |
Prevalence | not common |
Radiology | lung mass, usu. central location |
Prognosis | poor |
Clin. DDx | other lung tumours (squamous cell carcinoma of the lung), metastatic tumours |
Treatment | medical (chemotherapy) |
Small cell carcinoma of the lung, also small cell lung carcinoma (abbreviated SCLC)[1] is an aggressive malignant tumour of the lung. It is strongly associated with smoking.
General
- Strong association with smoking.
- Typically treated with chemotherapy.
- Poor prognosis.
On a spectrum of lesions (benign to malignant):[1]
- Tumourlet.
- Carcinoid.
- Atypical carcinoid.
- Small cell carinoma/large cell neuroendocrine carcinoma.
Precursor lesion - uncommonly seen:
- Pulmonary neuroendocrine cell hyperplasia.[1]
Clinical:
- +/-Hemoptysis.
Gross
- Central location (close to large airways) - typical.
- Necrosis.
Microscopic
Features:
- Stippled chromatin.
- High NC ratio, scant basophilic cytoplasm.
- Typically small cells ~2x RBC diameter.
- +/-Nuclear moulding.
- Nuclei with a smudgy appearance (Azzopardi phenomenon).
- Necrosis.
- Mitoses.
Notes:
- There should be no nucleolus.
DDx:
- Poorly differentiated adenocarcinoma of the lung.
- Metastatic small cell carcinoma.
- Lymphoma.
- Atypical carcinoid.
- Other small round blue cell tumours.
Subtypes
- Large cell neuroendocrine carcinoma (LCNEC).
Images
IHC
- Synaptophysin +ve.
- May be very weak.
- TTF-1 +ve (15 of 16 cases).[2]
Sign out
LOWER LOBE OF LUNG, LEFT, CORE BIOPSY: - SMALL CELL CARCINOMA.
See also
References
- ↑ 1.0 1.1 1.2 Travis, WD. (Oct 2010). "Advances in neuroendocrine lung tumors.". Ann Oncol 21 Suppl 7: vii65-71. doi:10.1093/annonc/mdq380. PMID 20943645.
- ↑ Wu, M.; Szporn, AH.; Zhang, D.; Wasserman, P.; Gan, L.; Miller, L.; Burstein, DE. (Oct 2005). "Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.". Diagn Cytopathol 33 (4): 223-7. doi:10.1002/dc.20337. PMID 16138374.